StockData
Contineum Therapeutics, Inc. logo

Contineum Therapeutics, Inc. (CTNM) income statement

CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$8.68−0.36 (-3.98%)

Close on Nov 20, 2026Market cap $326.55MP/E –Yield –

Contineum Therapeutics, Inc. financial ratios

See a number that looks wrong?